Follow this link for a second installment of questions and answers about regulations for hydrocodone combination products.
As of Aug. 22, 2014, the Drug Enforcement Administration (DEA) announced that hydrocodone combination products (HCPs) will be reclassified as Schedule II substances and subject to tighter restrictions to help reduce diversion, misuse, and abuse of prescription ...
This page is available to ADA members only